Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

The cryo-EM structure of a 12-subunit variant of RNA polymerase I reveals dissociation of the A49-A34.5 heterodimer and rearrangement of subunit A12.2.

Tafur L, Sadian Y, Hanske J, Wetzel R, Weis F, Müller CW.

Elife. 2019 Mar 26;8. pii: e43204. doi: 10.7554/eLife.43204.

2.

Structural insights into transcription initiation by yeast RNA polymerase I.

Sadian Y, Tafur L, Kosinski J, Jakobi AJ, Wetzel R, Buczak K, Hagen WJ, Beck M, Sachse C, Müller CW.

EMBO J. 2017 Sep 15;36(18):2698-2709. doi: 10.15252/embj.201796958. Epub 2017 Jul 24.

3.

Rotation thromboelastometry velocity curve predicts blood loss during liver transplantation.

Tafur LA, Taura P, Blasi A, Beltran J, Martinez-Palli G, Balust J, Garcia-Valdecasas JC.

Br J Anaesth. 2016 Dec;117(6):741-748.

4.

Molecular Structures of Transcribing RNA Polymerase I.

Tafur L, Sadian Y, Hoffmann NA, Jakobi AJ, Wetzel R, Hagen WJH, Sachse C, Müller CW.

Mol Cell. 2016 Dec 15;64(6):1135-1143. doi: 10.1016/j.molcel.2016.11.013. Epub 2016 Nov 17.

5.

Specialization versus conservation: How Pol I and Pol III use the conserved architecture of the pre-initiation complex for specialized transcription.

Hoffmann NA, Sadian Y, Tafur L, Kosinski J, Müller CW.

Transcription. 2016 Aug 7;7(4):127-32. doi: 10.1080/21541264.2016.1203628. Epub 2016 Jun 21. Review.

6.

[Incidence of cough after desflurane and sevoflurane administration through a laryngeal mask: a controlled clinical trial].

Lema FE, Tafur LA, Giraldo C, Delgado MA.

Rev Esp Anestesiol Reanim. 2010 Mar;57(3):141-6. Spanish.

PMID:
20422846
7.

Clearance of HPV infection in middle aged men and women after 9 years' follow up.

de Sanjose S, Bosch FX, Tafur LA, Nascimento CM, Izarzugaza I, Izquierdo A, Barricarte A, Shah KV, Meijer CJ, Muñoz N.

Sex Transm Infect. 2003 Aug;79(4):348. No abstract available.

8.

Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Colombia.

Smith J, Herrero R, Erles K, Grimm D, Muñoz N, Bosch FX, Tafur L, Shah KV, Schlehofer JR.

Int J Cancer. 2001 Nov;94(4):520-6.

9.

Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.

Viladiu P, Bosch FX, Castellsagué X, Muñoz N, Escribà JM, Hamsíkova E, Hofmannova V, Guerrero E, Izquierdo A, Navarro C, Moreo P, Izarzugaza I, Ascunce N, Gili M, Muñoz MT, Tafur L, Shah KV, Vonka V.

J Clin Oncol. 1997 Feb;15(2):610-9.

PMID:
9053484
10.

Risk factors for HPV DNA detection in middle-aged women.

Muñoz N, Kato I, Bosch FX, Eluf-Neto J, De Sanjosé S, Ascunce N, Gili M, Izarzugaza I, Viladiu P, Tormo MJ, Moreo P, Gonzalez LC, Tafur L, Walboomers JM, Shah KV.

Sex Transm Dis. 1996 Nov-Dec;23(6):504-10.

PMID:
8946637
11.

Socioeconomic differences in cervical cancer: two case-control studies in Colombia and Spain.

de Sanjosé S, Bosch FX, Muñoz N, Tafur L, Gili M, Izarzugaza I, Izquierdo A, Navarro C, Vergara A, Muñoz MT, Ascunce N, Shah KV.

Am J Public Health. 1996 Nov;86(11):1532-8.

12.

Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease.

Muñoz N, Castellsagué X, Bosch FX, Tafur L, de Sanjosé S, Aristizabal N, Ghaffari AM, Shah KV.

J Natl Cancer Inst. 1996 Aug 7;88(15):1068-75.

PMID:
8683638
13.

Serological response to HPV16 in CIN-III and cervical cancer patients. Case-control studies in Spain and Colombia.

De Sanjosé S, Hamsíková E, Muñoz N, Bosch FX, Hofmannová V, Gili M, Izarzugaza I, Viladiu P, Tormo MJ, Moreo P, Muñoz MT, Ascunce N, Tafur L, Shah KV, Vonka V.

Int J Cancer. 1996 Mar 28;66(1):70-4.

14.

Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer.

Moreno V, Muñoz N, Bosch FX, de Sanjosé S, Gonzalez LC, Tafur L, Gili M, Izarzugaza I, Navarro C, Vergara A, et al.

Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):459-67.

15.

Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia, with special reference to immunoglobulin-G sub-classes.

Muñoz N, Kato I, Bosch FX, De Sanjosé S, Sundquist VA, Izarzugaza I, Gonzalez LC, Tafur L, Gili M, Viladiu P, et al.

Int J Cancer. 1995 Feb 8;60(4):438-42.

PMID:
7829255
16.

Sexually transmitted agents and cervical neoplasia in Colombia and Spain.

de Sanjosé S, Muñoz N, Bosch FX, Reimann K, Pedersen NS, Orfila J, Ascunce N, González LC, Tafur L, Gili M, et al.

Int J Cancer. 1994 Feb 1;56(3):358-63.

PMID:
8314322
17.

Prostitution, HIV, and cervical neoplasia: a survey in Spain and Colombia.

de Sanjosé S, Palacio V, Tafur L, Vazquez S, Espitia V, Vazquez F, Roman G, Muñoz N, Bosch FX.

Cancer Epidemiol Biomarkers Prev. 1993 Nov-Dec;2(6):531-5.

18.

[Human papilloma virus in the etiology of cervicouterine cancer].

Muñoz N, Bosch FX, de Sanjosé S, Viladiu P, Tormo J, Moreo P, Ascunce N, González LC, Tafur L, Gili M, et al.

Bol Oficina Sanit Panam. 1993 Oct;115(4):301-9. Spanish.

PMID:
8240700
19.

Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia.

Muñoz N, Bosch FX, de Sanjosé S, Vergara A, del Moral A, Muñoz MT, Tafur L, Gili M, Izarzugaza I, Viladiu P, et al.

Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):423-31.

20.

Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia.

Bosch FX, Muñoz N, de Sanjosé S, Navarro C, Moreo P, Ascunce N, Gonzalez LC, Tafur L, Gili M, Larrañaga I, et al.

Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):415-22.

21.

The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain.

Muñoz N, Bosch FX, de Sanjosé S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N, et al.

Int J Cancer. 1992 Nov 11;52(5):743-9.

PMID:
1330933

Supplemental Content

Support Center